
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    As a professional computational biologist, I will meticulously analyze the provided list of highly expressed markers to identify the cell type from a human large intestine tissue dataset.<br><br>**Step-by-Step Analysis:**<br><br>**1. List the Key Functional Markers:**<br><br>This list is overwhelmingly dominated by genes involved in cell cycle progression, DNA replication, and mitosis.<br><br>*   **Cell Cycle Regulation/Mitosis:**<br>    *   **AURKB (Aurora Kinase B):** A key regulator of mitosis, involved in chromosome segregation and cytokinesis.<br>    *   **BIRC5 (Survivin):** An anti-apoptotic protein and a crucial component of the chromosomal passenger complex (CPC), essential for proper chromosome segregation and cytokinesis.<br>    *   **CENPA (Centromere Protein A):** A histone H3 variant specific to centromeres, essential for kinetochore assembly and chromosome segregation.<br>    *   **CEP55 (Centrosomal Protein 55):** Involved in cytokinesis, localizing to the midbody.<br>    *   **CKAP2L (Cytoskeleton Associated Protein 2 Like):** Implicated in cell division.<br>    *   **DLGAP5 (DLG Associated Protein 5):** Involved in spindle organization and chromosome segregation.<br>    *   **FOXM1 (Forkhead Box M1):** A transcription factor critical for cell cycle progression, particularly G2/M transition and mitosis. Often considered a master regulator of proliferation.<br>    *   **GTSE1 (G2 and S-phase Expressed 1):** Involved in cell cycle regulation, particularly in G2/M.<br>    *   **HJURP (Holliday Junction Recognition Protein):** Involved in CENP-A deposition at centromeres, crucial for chromosome inheritance.<br>    *   **KIF2C (Kinesin Family Member 2C), KIF15 (Kinesin Family Member 15), KIF18B (Kinesin Family Member 18B):** Kinesin motor proteins involved in various aspects of mitosis, including spindle assembly and chromosome movement.<br>    *   **MKI67 (Marker of Proliferation Ki-67):** A well-established nuclear protein associated with cell proliferation. Its expression is strictly associated with cell division.<br>    *   **NCAPG (Non-SMC Condensin I Complex Subunit G):** A subunit of the condensin complex, essential for chromosome condensation during mitosis.<br>    *   **NEK2 (NIMA Related Kinase 2):** Involved in centrosome separation and spindle formation.<br>    *   **OIP5 (OPA-Interacting Protein 5):** Involved in mitotic spindle assembly and chromosome segregation.<br>    *   **PBK (PDZ Binding Kinase):** A mitotic kinase involved in cell cycle progression.<br>    *   **PIMREG (PIM Kinase Regulator):** Involved in cell cycle regulation.<br>    *   **PLK1 (Polo-like Kinase 1):** A key regulator of multiple mitotic events, including centrosome maturation, spindle assembly, and cytokinesis.<br>    *   **SKA1 (Spindle and Kinetochore Associated 1), SKA3 (Spindle and Kinetochore Associated 3):** Components of the SKA complex, essential for stable microtubule-kinetochore attachments during mitosis.<br>    *   **SPC24 (NDC80 Kinetochore Complex Component), SPC25 (NDC80 Kinetochore Complex Component):** Components of the NDC80 complex, crucial for kinetochore-microtubule attachment.<br>    *   **TOP2A (DNA Topoisomerase II Alpha):** Essential for DNA replication and chromosome segregation, involved in resolving DNA tangles.<br>    *   **TTK (Dual Specificity Tyrosine Phosphorylation Regulated Kinase):** A mitotic kinase involved in the spindle assembly checkpoint.<br>    *   **UBE2C (Ubiquitin Conjugating Enzyme E2 C):** Involved in the anaphase-promoting complex/cyclosome (APC/C) pathway, crucial for cell cycle progression.<br><br>*   **DNA Replication/Repair:**<br>    *   **CDT1 (Chromatin Licensing And DNA Replication Factor 1):** Essential for DNA replication initiation.<br>    *   **GINS2 (GINS Complex Subunit 2):** A component of the GINS complex, essential for DNA replication fork progression.<br>    *   **POLQ (DNA Polymerase Theta):** Involved in DNA repair, particularly alternative end-joining.<br>    *   **RAD51AP1 (RAD51 Associated Protein 1):** Involved in homologous recombination and DNA repair.<br>    *   **RRM2 (Ribonucleotide Reductase M2):** Catalyzes the rate-limiting step in dNTP synthesis, essential for DNA replication.<br>    *   **TK1 (Thymidine Kinase 1):** Involved in the salvage pathway for dNTP synthesis, essential for DNA replication.<br><br>*   **Other Cell Cycle Related:**<br>    *   **CCNB2 (Cyclin B2):** A B-type cyclin, essential for mitotic entry and progression.<br>    *   **CDC25C (Cell Division Cycle 25C):** A phosphatase that activates CDK1, promoting mitotic entry.<br>    *   **CDC45 (Cell Division Cycle 45):** Involved in DNA replication initiation and elongation.<br>    *   **CDCA3 (Cell Division Cycle Associated 3), CDCA5 (Cell Division Cycle Associated 5):** Proteins involved in cell cycle regulation.<br>    *   **CDK1 (Cyclin Dependent Kinase 1):** A master regulator of mitotic entry and progression.<br>    *   **DEPDC1 (DEP Domain Containing 1):** Implicated in cell proliferation.<br>    *   **DIAPH3 (Diaphanous Related Formin 3):** Involved in cytokinesis.<br>    *   **DTL (Denticleless E3 Ubiquitin Protein Ligase Homolog):** Involved in DNA damage response and cell cycle control.<br>    *   **IQGAP3 (IQ Motif And GAP Related Protein 3):** Involved in cell proliferation and migration.<br>    *   **MND1 (Meiotic Nuclear Division 1 Homolog):** Involved in homologous recombination and DNA repair, particularly in meiosis but also expressed in proliferating somatic cells.<br>    *   **NUF2 (NDC80 Kinetochore Complex Component):** A component of the NDC80 complex, crucial for kinetochore-microtubule attachment.<br>    *   **PCLAF (PCNA-Associated Factor):** Involved in DNA replication and repair.<br>    *   **PKMYT1 (Protein Kinase, Myelin Transcription Factor 1):** A kinase that inhibits CDK1, involved in G2/M checkpoint.<br>    *   **ZNF695 (Zinc Finger Protein 695):** Less directly linked to cell cycle, but some zinc finger proteins are involved in transcriptional regulation of cell cycle genes.<br><br>**2. List the Key Cell Type Markers:**<br><br>Based on the provided list, there are no specific markers that definitively point to a *differentiated* cell type within the large intestine (e.g., enterocytes, goblet cells, Paneth cells, immune cells, fibroblasts, etc.). Instead, the entire list is overwhelmingly composed of genes associated with active cell division.<br><br>**3. Cross-reference Known Databases:**<br><br>A quick search of these markers (e.g., MKI67, TOP2A, AURKB, BIRC5, KIF2C, CCNB2, CDK1, FOXM1) in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker) consistently identifies them as markers for:<br><br>*   **Proliferating cells**<br>*   **Dividing cells**<br>*   **Cells in S/G2/M phase**<br>*   **Stem cells (specifically, actively dividing stem cells)**<br>*   **Cancer cells (due to their high proliferative capacity)**<br><br>In the context of normal large intestine tissue, the most actively proliferating cell populations are:<br><br>*   **Intestinal Stem Cells (ISCs):** Located at the base of the crypts, responsible for continuous renewal of the intestinal epithelium.<br>*   **Transit Amplifying (TA) Cells:** Progeny of ISCs that undergo several rounds of division as they migrate up the crypt before differentiating.<br><br>**4. Determine the Most Probable General Cell Type:**<br><br>Given the overwhelming enrichment of genes involved in cell cycle, DNA replication, and mitosis, the most probable general cell type is **Proliferating Cells**. This cluster represents cells actively undergoing division.<br><br>**5. Identify the Top 3 Most Probable Sub Cell Types:**<br><br>Within the context of the large intestine, and considering the high proliferative activity, the top 3 most probable sub cell types are:<br><br>1.  **Intestinal Stem Cells (ISCs) / Crypt Base Columnar (CBC) Cells:** These are the primary self-renewing cells at the base of the crypts, characterized by high proliferative activity to maintain the epithelial lining. Markers like *LGR5* are canonical for ISCs, but their absence in this list doesn't rule out ISCs, as this list focuses on *proliferation* markers rather than specific stemness markers. The presence of a large number of cell cycle genes is highly consistent with the rapid division of ISCs.<br>2.  **Transit Amplifying (TA) Cells:** These cells are the immediate progeny of ISCs and undergo rapid rounds of division as they migrate upwards from the crypt base. They are highly proliferative and would express a similar set of cell cycle markers as ISCs, albeit potentially with some subtle differences in the exact balance or intensity of expression as they commit to differentiation.<br>3.  **Activated Immune Cells (e.g., Proliferating T cells):** While less likely to be the *primary* component of such a strong and broad proliferative signature in a general tissue sample unless there's inflammation, immune cells (especially T cells) can proliferate extensively upon activation. However, this list lacks typical immune cell markers (e.g., CD3, CD8, CD4, CD19, PTPRC/CD45). Therefore, while possible, it's less probable as the dominant cell type compared to the epithelial lineage.<br><br>**Most Likely Subtype:**<br><br>Based on the sheer number and high expression of core cell cycle and mitotic genes, the most likely subtype is **Transit Amplifying (TA) Cells**, closely followed by Intestinal Stem Cells (ISCs). TA cells are known for their rapid and extensive proliferation, making them a strong candidate for a cluster defined by such a robust proliferative signature. ISCs also proliferate rapidly, but TA cells represent a larger population undergoing active division as they expand the lineage. Without specific stem cell markers (like LGR5) or differentiation markers, distinguishing definitively between ISCs and early TA cells based *solely* on proliferation markers can be challenging, as both are highly proliferative. However, the breadth and intensity of the proliferative signature strongly suggest a population undergoing rapid expansion, which is characteristic of TA cells.<br><br>**Concise Summary of Analysis:**<br><br>The provided marker list is overwhelmingly enriched for genes involved in cell cycle progression, DNA replication, and mitosis (e.g., MKI67, TOP2A, AURKB, BIRC5, KIF2C, CCNB2, CDK1, FOXM1). This indicates a highly proliferative cell population. In the context of human large intestine tissue, the most actively dividing cells are found within the epithelial crypts. Therefore, the general cell type is **Proliferating Cells**. The top three most probable sub cell types are **Transit Amplifying (TA) Cells**, **Intestinal Stem Cells (ISCs)**, and less likely, activated immune cells. Given the extensive and broad proliferative signature, the most likely specific subtype is **Transit Amplifying (TA) Cells**, which are responsible for rapid epithelial renewal in the intestine.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED
                </div>
            
                    <div class="agent-section formatting">
                        <h2>üìã Summary</h2>
                        <p class="error-message">Error formatting data: Expecting value: line 1 column 1 (char 0)</p>
                    </div>
                
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">98</div>
                        <div class="scoring-content">
                            The annotation provided is exceptionally thorough and accurate. The agent correctly identifies the overwhelming presence of cell cycle, DNA replication, and mitosis-related genes in the marker list.<br><br>**Strengths:**<br>1.  **Comprehensive Marker Analysis:** The step-by-step analysis meticulously categorizes markers into "Cell Cycle Regulation/Mitosis" and "DNA Replication/Repair," and "Other Cell Cycle Related," demonstrating a deep understanding of gene function. This detailed breakdown reinforces the conclusion that the cluster represents proliferating cells.<br>2.  **Contextualization within Tissue:** The agent effectively contextualizes the findings within the human large intestine, correctly identifying Intestinal Stem Cells (ISCs) and Transit Amplifying (TA) Cells as the main proliferative populations in this tissue. This shows an understanding of tissue-specific biology.<br>3.  **Prioritization of Proliferation:** The agent correctly prioritizes the "Proliferating Cells" as the main cell type, acknowledging that the marker list is not indicative of a specific differentiated cell type but rather a state of high proliferation.<br>4.  **Consideration of Marker Importance:** While the prompt mentions the rank of markers, the agent implicitly handles this by recognizing the *entire set* as a strong signature of proliferation, rather than over-focusing on just the first few. The consistency across a large number of markers is a more robust indicator than the rank of one or two.<br>5.  **Exclusion of Unlikely Candidates:** The agent correctly dismisses activated immune cells as the primary component due to the lack of specific immune markers, demonstrating sound reasoning.<br>6.  **Nuanced Distinction between ISCs and TA Cells:** The explanation for distinguishing between ISCs and TA cells is well-reasoned, highlighting the challenge without specific stemness markers but leaning towards TA cells due to their extensive and rapid proliferation.<br>7.  **Clear and Logical Flow:** The step-by-step analysis is easy to follow and logically progresses from marker identification to tissue-specific context and final annotation.<br><br>**Weaknesses:**<br>1.  **Implicit Marker Ranking:** While the agent does a good job considering the breadth of markers, it doesn't explicitly state how the "rank" of the markers (i.e., the order in which they appear) was considered, as requested in the prompt. However, given that all listed markers are highly proliferative, the rank might be less critical here than in other scenarios where the top markers might strongly indicate a specific cell type. The agent effectively uses the *collective* signal of a large number of highly correlated proliferative markers, which is a more robust approach.<br><br>Overall, the annotation is highly accurate, well-justified, and demonstrates expert knowledge in single-cell analysis and biological context. It captures the overall picture of a highly proliferative cell population within the large intestine effectively.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    